|
1
|
Mollayeva T, Mollayeva S and Colantonio A:
Traumatic brain injury: Sex, gender and intersecting
vulnerabilities. Nat Rev Neurol. 14:711–722. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
NAEMT in Cooporetion with American College
of Surgeons, Committee Trauma. Chapter 8 Head Trauma. In: PHTLS,
Prehospital Trauma Life Support. Ninth. Burlington, MA: Jones &
Bartlett Learning; 2023.
|
|
3
|
Khellaf A, Khan DZ and Helmy A: Recent
advances in traumatic brain injury. J Neurol. 266:2878–2889.
2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Vella MA, Crandall ML and Patel MB: Acute
management of traumatic brain injury. Surg Clin North Am.
97:1015–1030. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Williamson C and Rajajee V: Traumatic
brain injury: Epidemiology, classification, and pathophysiology.
In: UpToDate. UpToDate, Post TW. UpToDate, Waltham, MA; 2023.
|
|
6
|
Menon DK, Schwab K, Wright DW and Maas AI:
Demographics and Clinical Assessment Working Group of the
International and Interagency Initiative toward Common Data
Elements for Research on Traumatic Brain Injury and Psychological
Health. Position statement: Definition of traumatic brain injury.
Arch Phys Med Rehabil. 91:1637–1640. 2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Capizzi A, Woo J and Verduzco-Gutierrez M:
Traumatic brain injury: An overview of epidemiology,
pathophysiology, and medical management. Med Clin North Am.
104:213–238. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Dixon KJ: Pathophysiology of traumatic
brain injury. Phys Med Rehabil Clin N Am. 28:215–225.
2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Galgano M, Toshkezi G, Qiu X, Russell T,
Chin L and Zhao LR: Traumatic brain injury: Current treatment
strategies and future endeavors. Cell Transplant. 26:1118–1130.
2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wang KK, Yang Z, Zhu T, Shi Y, Rubenstein
R, Tyndall JA and Manley GT: An update on diagnostic and prognostic
biomarkers for traumatic brain injury. Expert Rev Mol Diagn.
18:165–180. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Pearn ML, Niesman IR, Egawa J, Sawada A,
Almenar-Queralt A, Shah SB, Duckworth JL and Head BP:
Pathophysiology associated with traumatic brain injury: Current
treatments and potential novel therapeutics. Cell Mol Neurobiol.
37:571–585. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sulhan S, Lyon KA, Shapiro LA and Huang
JH: Neuroinflammation and blood-brain barrier disruption following
traumatic brain injury: Pathophysiology and potential therapeutic
targets. J Neurosci Res. 98:19–28. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
MRC CRASH Trial Collaborators. Perel P,
Arango M, Clayton T, Edwards P, Komolafe E, Poccock S, Roberts I,
Shakur H, Steyerberg E and Yutthakasemsunt S: Predicting outcome
after traumatic brain injury: Practical prognostic models based on
large cohort of international patients. BMJ. 336:425–429.
2008.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kempuraj D, Selvakumar GP, Ahmed ME,
Raikwar SP, Thangavel R, Khan A, Zaheer SA, Iyer SS, Burton C,
James D and Zaheer A: COVID-19, mast cells, cytokine storm,
psychological stress, and neuroinflammation. Neuroscientist.
26:402–414. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Najem D, Rennie K, Ribecco-Lutkiewicz M,
Ly D, Haukenfrers J, Liu Q, Nzau M, Fraser DD and Bani-Yaghoub M:
Traumatic brain injury: Classification, models, and markers.
Biochem Cell Biol Biochim Biol Cell. 96:391–406. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
McGinn MJ and Povlishock JT:
Pathophysiology of traumatic brain injury. Neurosurg Clin N Am.
27:397–407. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Mark S: Greenberg. Handbook of
Neurosurgery [Internet]. [cited 2022 May 30]. Available from:
https://medone.thieme.com/ebooks/cs_9872229?context=coverpage&fromSearch=false#/ebook_cs_9872229_d1e266595.
|
|
18
|
Karve IP, Taylor JM and Crack PJ: The
contribution of astrocytes and microglia to traumatic brain injury.
Br J Pharmacol. 173:692–702. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Johnston RB: An overview of the innate
immune system. In: UpToDate Post TW. UpToDate, Waltham, MA;
2023.
|
|
20
|
Jassam YN, Izzy S, Whalen M, McGavern DB
and El Khoury J: Neuroimmunology of Traumatic Brain Injury: Time
for a Paradigm Shift. Neuron. 95:1246–1265. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Prognostic calculator|TBI-IMPACT.org [Internet]. [cited 2022 Dec 4].
Available from: http://www.tbi-impact.org/?p=impact/calc.
|
|
22
|
Mozaffari K, Dejam D, Duong C, Ding K,
French A, Ng E, Preet K, Franks A, Kwan I, Phillips HW, et al:
Systematic review of serum biomarkers in traumatic brain injury.
Cureus. 13(e17056)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Nishimura K, Cordeiro JG, Ahmed AI,
Yokobori S and Gajavelli S: Advances in traumatic brain injury
biomarkers. Cureus. 14(e23804)2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wang KKW, Kobeissy FH, Shakkour Z and
Tyndall JA: Thorough overview of ubiquitin C-terminal hydrolase-L1
and glial fibrillary acidic protein as tandem biomarkers recently
cleared by US Food and Drug Administration for the evaluation of
intracranial injuries among patients with traumatic brain injury.
Acute Med Surg. 8(e622)2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Hier DB, Obafemi-Ajayi T, Thimgan MS,
Olbricht GR, Azizi S, Allen B, Hadi BA and Wunsch DC II: Blood
biomarkers for mild traumatic brain injury: A selective review of
unresolved issues. Biomark Res. 9(70)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Middleton J: UCH-L1 and GFAP Testing
(i-STAT TBI Plasma) for the detection of intracranial injury
following mild traumatic brain injury. Am Fam Physician.
105:313–314. 2022.PubMed/NCBI
|
|
27
|
Korfias S, Stranjalis G, Papadimitriou A,
Psachoulia C, Daskalakis G, Antsaklis A and Sakas DE: Serum S-100B
protein as a biochemical marker of brain injury: A review of
current concepts. Curr Med Chem. 13:3719–3731. 2006.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Amoo M, Henry J, O'Halloran PJ, Brennan P,
Husien MB, Campbell M, Caird J, Javadpour M and Curley GF: S100B,
GFAP, UCH-L1 and NSE as predictors of abnormalities on CT imaging
following mild traumatic brain injury: A systematic review and
meta-analysis of diagnostic test accuracy. Neurosurg Rev.
45:1171–1193. 2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Korfias S, Stranjalis G, Boviatsis E,
Psachoulia C, Jullien G, Gregson B, Mendelow AD and Sakas DE: Serum
S-100B protein monitoring in patients with severe traumatic brain
injury. Intensive Care Med. 33:255–260. 2007.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Janigro D, Mondello S, Posti JP and Unden
J: GFAP and S100B: What you always wanted to know and never dared
to ask. Front Neurol. 13(835597)2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Frankel M, Fan L, Yeatts SD, Jeromin A,
Vos PE, Wagner AK, Wolf BJ, Pauls Q, Lunney M, Merck LH, et al:
Association of very early serum levels of S100B, glial fibrillary
acidic protein, Ubiquitin C-Terminal Hydrolase-L1, and spectrin
breakdown product with outcome in ProTECT III. J Neurotrauma.
36:2863–2871. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Thelin EP, Zeiler FA, Ercole A, Mondello
S, Büki A, Bellander BM, Helmy A, Menon DK and Nelson DW: Serial
sampling of serum protein biomarkers for monitoring human traumatic
brain injury dynamics: A systematic review. Front Neurol.
8(300)2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Korfias S, Papadimitriou A, Stranjalis G,
Bakoula C, Daskalakis G, Antsaklis A and Sakas DE: Serum
biochemical markers of brain injury. Mini Rev Med Chem. 9:227–234.
2009.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Minkkinen M, Iverson GL, Kotilainen AK,
Pauniaho SL, Mattila VM, Lehtimäki T, Berghem K, Posti JP and Luoto
TM: Prospective validation of the scandinavian guidelines for
initial management of minimal, mild, and moderate head injuries in
adults. J Neurotrauma. 36:2904–2912. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kang S, Narazaki M, Metwally H and
Kishimoto T: Historical overview of the interleukin-6 family
cytokine. J Exp Med. 217(e20190347)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Rose-John S: Interleukin-6 signalling in
health and disease. F1000Res 9: F1000 Faculty Rev-1013, 2020.
|
|
37
|
Rose-John S: Interleukin-6 family
cytokines. Cold Spring Harb Perspect Biol.
10(a028415)2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Sanchis P, Fernández-Gayol O, Vizueta J,
Comes G, Canal C, Escrig A, Molinero A, Giralt M and Hidalgo J:
Microglial cell-derived interleukin-6 influences behavior and
inflammatory response in the brain following traumatic brain
injury. Glia. 68:999–1016. 2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ooi SZY, Spencer RJ, Hodgson M, Mehta S,
Phillips NL, Preest G, Manivannan S, Wise MP, Galea J and Zaben M:
Interleukin-6 as a prognostic biomarker of clinical outcomes after
traumatic brain injury: A systematic review. Neurosurg Rev.
45:3035–3054. 2022.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Li Z, Xiao J, Xu X, Li W, Zhong R, Qi L,
Chen J, Cui G, Wang S, Zheng Y, et al: M-CSF, IL-6, and TGF-β
promote generation of a new subset of tissue repair macrophage for
traumatic brain injury recovery. Sci Adv.
7(eabb6260)2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Matsushima K and Oppenheim JJ: Interleukin
8 and MCAF: Novel inflammatory cytokines inducible by IL 1 and TNF.
Cytokine. 1:2–13. 1989.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Dobreva I, Waeber G, James RW and Widmann
C: Interleukin-8 secretion by fibroblasts induced by low density
lipoproteins is p38 MAPK-dependent and leads to cell spreading and
wound closure. J Biol Chem. 281:199–205. 2006.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Lieberman MM, Sachanandani DM and Pinney
CA: Comparative study of neutrophil activation by chemiluminescence
and flow cytometry. Clin Diagn Lab Immunol. 3:654–662.
1996.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Bickel M: The role of interleukin-8 in
inflammation and mechanisms of regulation. J Periodontol. 64 (5
Suppl):S456–S460. 1993.PubMed/NCBI
|
|
45
|
Hack CE, Hart M, van Schijndel RJ,
Eerenberg AJ, Nuijens JH, Thijs LG and Aarden LA: Interleukin-8 in
sepsis: Relation to shock and inflammatory mediators. Infect Immun.
60:2835–2842. 1992.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Woodcock T and Morganti-Kossmann MC: The
role of markers of inflammation in traumatic brain injury. Front
Neurol. 4(18)2013.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Lewis CT, Savarraj JPJ, McGuire MF,
Hergenroeder GW, Alex Choi H and Kitagawa RS: Elevated inflammation
and decreased platelet activity is associated with poor outcomes
after traumatic brain injury. J Clin Neurosci. 70:37–41.
2019.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Maiti P, Peruzzaro S, Kolli N, Andrews M,
Al-Gharaibeh A, Rossignol J and Dunbar GL: Transplantation of
mesenchymal stem cells overexpressing interleukin-10 induces
autophagy response and promotes neuroprotection in a rat model of
TBI. J Cell Mol Med. 23:5211–5224. 2019.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Csuka E, Morganti-Kossmann MC, Lenzlinger
PM, Joller H, Trentz O and Kossmann T: IL-10 levels in
cerebrospinal fluid and serum of patients with severe traumatic
brain injury: Relationship to IL-6, TNF-alpha, TGF-beta1 and
blood-brain barrier function. J Neuroimmunol. 101:211–221.
1999.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Wen L, Wang YD, Shen DF, Zheng PD, Tu MD,
You WD, Zhu YR, Wang H, Feng JF and Yang XF: Exosomes derived from
bone marrow mesenchymal stem cells inhibit neuroinflammation after
traumatic brain injury. Neural Regen Res. 17:2717–2724.
2022.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Garcia JM, Stillings SA, Leclerc JL,
Phillips H, Edwards NJ, Robicsek SA, Hoh BL, Blackburn S and Doré
S: Role of Interleukin-10 in Acute Brain Injuries. Front Neurol.
8(244)2017.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Unal I: Defining an optimal cut-point
value in ROC analysis: An alternative approach. Comput Math Methods
Med. 2017(3762651)2017.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Korley FK, Jain S, Sun X, Puccio AM, Yue
JK, Gardner RC, Wang KKW, Okonkwo DO, Yuh EL, Mukherjee P, et al:
Prognostic value of day-of-injury plasma GFAP and UCH-L1
concentrations for predicting functional recovery after traumatic
brain injury in patients from the US TRACK-TBI cohort: An
observational cohort study. Lancet Neurol. 21:803–813.
2022.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Takala RSK, Posti JP, Runtti H, Newcombe
VF, Outtrim J, Katila AJ, Frantzén J, Ala-Seppälä H, Kyllönen A,
Maanpää HR, et al: Glial fibrillary acidic protein and ubiquitin
C-Terminal Hydrolase-L1 as outcome predictors in traumatic brain
injury. World Neurosurg. 87:8–20. 2016.PubMed/NCBI View Article : Google Scholar
|
|
55
|
McKee CA and Lukens JR: Emerging roles for
the immune system in traumatic brain injury. Front Immunol.
7(556)2016.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Rodney T, Taylor P, Dunbar K, Perrin N,
Lai C, Roy M and Gill J: High IL-6 in military personnel relates to
multiple traumatic brain injuries and post-traumatic stress
disorder. Behav Brain Res. 392(112715)2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Bell MJ, Kochanek PM, Doughty LA, Carcillo
JA, Adelson PD, Clark RS, Whalen MJ and DeKosky ST: Comparison of
the interleukin-6 and interleukin-10 response in children after
severe traumatic brain injury or septic shock. Acta Neurochir
Suppl. 70:96–97. 1997.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Kossmann T, Hans V, Imhof HG, Trentz O and
Morganti-Kossmann MC: Interleukin-6 released in human cerebrospinal
fluid following traumatic brain injury may trigger nerve growth
factor production in astrocytes. Brain Res. 713:143–152.
1996.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Ondruschka B, Schuch S, Pohlers D, Franke
H and Dreßler J: Acute phase response after fatal traumatic brain
injury. Int J Legal Med. 132:531–539. 2018.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Thompson HJ, Martha SR, Wang J and Becker
KJ: Impact of age on plasma inflammatory biomarkers in the 6 months
following mild traumatic brain injury. J Head Trauma Rehabil.
35:324–331. 2020.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Bell MJ, Kochanek PM, Doughty LA, Carcillo
JA, Adelson PD, Clark RS, Whalen MJ and DeKosky ST: Interleukin-6
and interleukin-10 in cerebrospinal fluid after severe traumatic
brain injury in children. J Neurotrauma. 14:451–457.
1997.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Liao Y, Liu P, Guo F, Zhang ZY and Zhang
Z: Oxidative burst of circulating neutrophils following traumatic
brain injury in human. PLoS One. 8(e68963)2013.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Hergenroeder GW, Moore AN, McCoy JP,
Samsel L, Ward NH III, Clifton GL and Dash PK: Serum IL-6: A
candidate biomarker for intracranial pressure elevation following
isolated traumatic brain injury. J Neuroinflammation.
7(19)2010.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Terrell TR, Abramson R, Barth JT, Bennett
E, Cantu RC, Sloane R, Laskowitz DT, Erlanger DM, McKeag D, Nichols
G, et al: Genetic polymorphisms associated with the risk of
concussion in 1056 college athletes: A multicentre prospective
cohort study. Br J Sports Med. 52:192–198. 2018.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Pierce ME, Hayes J, Huber BR, Jeromin A,
Fortier CB, Fonda JR, Lasseter H, Chaby L, McGlinchey R and Milberg
W: Plasma biomarkers associated with deployment trauma and its
consequences in post-9/11 era veterans: Initial findings from the
TRACTS longitudinal cohort. Transl Psychiatry.
12(80)2022.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Gill J, Motamedi V, Osier N, Dell K,
Arcurio L, Carr W, Walker P, Ahlers S, Lopresti M and Yarnell A:
Moderate blast exposure results in increased IL-6 and TNFα in
peripheral blood. Brain Behav Immun. 65:90–94. 2017.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Hayakata T, Shiozaki T, Tasaki O, Ikegawa
H, Inoue Y, Toshiyuki F, Hosotubo H, Kieko F, Yamashita T, Tanaka
H, et al: Changes in CSF S100B and cytokine concentrations in
early-phase severe traumatic brain injury. Shock Augusta Ga.
22:102–107. 2004.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Meier TB, Huber DL, Bohorquez-Montoya L,
Nitta ME, Savitz J, Teague TK, Bazarian JJ, Hayes RL, Nelson LD and
McCrea MA: A prospective study of acute blood-based biomarkers for
sport-related concussion. Ann Neurol. 87:907–920. 2020.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Lustenberger T, Kern M, Relja B, Wutzler
S, Störmann P and Marzi I: The effect of brain injury on the
inflammatory response following severe trauma. Immunobiology.
221:427–431. 2016.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Meier TB, Guedes VA, Smith EG, Sass D,
Mithani S, Vorn R, Savitz J, Teague TK, McCrea MA and Gill JM:
Extracellular vesicle-associated cytokines in sport-related
concussion. Brain Behav Immun. 100:83–87. 2022.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Edwards KA, Gill JM, Pattinson CL, Lai C,
Brière M, Rogers NJ, Milhorn D, Elliot J and Carr W: Interleukin-6
is associated with acute concussion in military combat personnel.
BMC Neurol. 20(209)2020.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Yang DB, Yu WH, Dong XQ, Zhang ZY, Du Q,
Zhu Q, Che ZH, Wang H, Shen YF and Jiang L: Serum macrophage
migration inhibitory factor concentrations correlate with prognosis
of traumatic brain injury. Clin Chim Acta Int J Clin Chem.
469:99–104. 2017.PubMed/NCBI View Article : Google Scholar
|
|
73
|
McKeating EG, Andrews PJ, Signorini DF and
Mascia L: Transcranial cytokine gradients in patients requiring
intensive care after acute brain injury. Br J Anaesth. 78:520–523.
1997.PubMed/NCBI View Article : Google Scholar
|
|
74
|
He LM, Qiu BH, Qi ST, Fang LX and Liu XJ:
Dynamic changes of serum interleukin-6 and interleukin-8 in
patients with acute traumatic brain injury and the clinical
significance. Nan Fang Yi Ke Da Xue Xue Bao. 29:999–1001.
2009.PubMed/NCBI(In Chinese).
|
|
75
|
Chiaretti A, Genovese O, Aloe L, Antonelli
A, Piastra M, Polidori G and Di Rocco C: Interleukin 1beta and
interleukin 6 relationship with paediatric head trauma severity and
outcome. Childs Nerv Syst. 21:185–194. 2005.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Park SH and Hwang SK: Prognostic value of
serum levels of S100 calcium-binding protein B, neuron-specific
enolase, and interleukin-6 in pediatric patients with traumatic
brain injury. World Neurosurg. 118:e534–e542. 2018.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Chiaretti A, Antonelli A, Riccardi R,
Genovese O, Pezzotti P, Di Rocco C, Tortorolo L and Piedimonte G:
Nerve growth factor expression correlates with severity and outcome
of traumatic brain injury in children. Eur J Paediatr Neurol.
12:195–204. 2008.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Vajtr D, Benada O, Kukacka J, Průša R,
Houstava L, Ťoupalík P and Kizek R: Correlation of ultrastructural
changes of endothelial cells and astrocytes occurring during blood
brain barrier damage after traumatic brain injury with biochemical
markers of BBB leakage and inflammatory response. Physiol Res.
58:263–268. 2009.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Mellergård P, Åneman O, Sjögren F, Säberg
C and Hillman J: Differences in cerebral extracellular response of
interleukin-1β, interleukin-6, and interleukin-10 after
subarachnoid hemorrhage or severe head trauma in humans.
Neurosurgery. 68:12–19. 2011.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Pleines UE, Morganti-Kossmann MC, Rancan
M, Joller H, Trentz O and Kossmann T: S-100 beta reflects the
extent of injury and outcome, whereas neuronal specific enolase is
a better indicator of neuroinflammation in patients with severe
traumatic brain injury. J Neurotrauma. 18:491–498. 2001.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Singhal A, Baker AJ, Hare GMT, Reinders
FX, Schlichter LC and Moulton RJ: Association between cerebrospinal
fluid interleukin-6 concentrations and outcome after severe human
traumatic brain injury. J Neurotrauma. 19:929–937. 2002.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Aisiku IP, Yamal JM, Doshi P, Benoit JS,
Gopinath S, Goodman JC and Robertson CS: Plasma cytokines IL-6,
IL-8, and IL-10 are associated with the development of acute
respiratory distress syndrome in patients with severe traumatic
brain injury. Crit Care Lond Engl. 20(288)2016.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Davidson J, Cusimano MD and Bendena WG:
Post-Traumatic brain injury: Genetic susceptibility to outcome.
Neuroscientist. 21:424–441. 2015.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Woiciechowsky C, Schöning B, Cobanov J,
Lanksch WR, Volk HD and Döcke WD: Early IL-6 plasma concentrations
correlate with severity of brain injury and pneumonia in
brain-injured patients. J Trauma. 52:339–345. 2002.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Peltz CB, Kenney K, Gill J, Diaz-Arrastia
R, Gardner RC and Yaffe K: Blood biomarkers of traumatic brain
injury and cognitive impairment in older veterans. Neurology.
95:e1126–e1133. 2020.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Winter CD, Pringle AK, Clough GF and
Church MK: Raised parenchymal interleukin-6 levels correlate with
improved outcome after traumatic brain injury. Brain J Neurol.
127:315–320. 2004.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Nwachuku EL, Puccio AM, Adeboye A, Chang
YF, Kim J and Okonkwo DO: Time course of cerebrospinal fluid
inflammatory biomarkers and relationship to 6-month neurologic
outcome in adult severe traumatic brain injury. Clin Neurol
Neurosurg. 149:1–5. 2016.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Feng MJ, Ning WB, Wang W, Lv ZH, Liu XB,
Zhu Y, Gao W, Jin HZ and Gao SS: Serum S100A12 as a prognostic
biomarker of severe traumatic brain injury. Clin Chim Acta Int J
Clin Chem. 480:84–91. 2018.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Ferreira LCB, Regner A, Miotto KDL, de
Moura S, Ikuta N, Vargas AE, Chies JA and Simon D: Increased levels
of interleukin-6, -8 and -10 are associated with fatal outcome
following severe traumatic brain injury. Brain Inj. 28:1311–1316.
2014.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Kumar RG, Diamond ML, Boles JA, Berger RP,
Tisherman SA, Kochanek PM and Wagner AK: Acute CSF interleukin-6
trajectories after TBI: Associations with neuroinflammation,
polytrauma, and outcome. Brain Behav Immun. 45:253–262.
2015.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Raheja A, Sinha S, Samson N, Bhoi S,
Subramanian A, Sharma P and Sharma BS: Serum biomarkers as
predictors of long-term outcome in severe traumatic brain injury:
Analysis from a randomized placebo-controlled phase II clinical
trial. J Neurosurg. 125:631–641. 2016.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Zwirner J, Bohnert S, Franke H, Garland J,
Hammer N, Möbius D, Tse R and Ondruschka B: Assessing protein
biomarkers to detect lethal acute traumatic brain injuries in
cerebrospinal fluid. Biomolecules. 11(1577)2021.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Crichton A, Ignjatovic V, Babl FE, Oakley
E, Greenham M, Hearps S, Delzoppo C, Beauchamp MH, Guerguerian AM,
Boutis K, et al: Interleukin-8 Predicts Fatigue at 12 months
post-injury in children with traumatic brain injury. J Neurotrauma.
38:1151–1163. 2021.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Lagerstedt L, Azurmendi L, Tenovuo O,
Katila AJ, Takala RSK, Blennow K, Newcombe VFJ, Maanpää HR, Tallus
J, Hossain I, et al: Interleukin 10 and heart fatty acid-binding
protein as early outcome predictors in patients with traumatic
brain injury. Front Neurol. 11(376)2020.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Lagerstedt L, Egea-Guerrero JJ, Bustamante
A, Rodríguez-Rodríguez A, El Rahal A, Quintana-Diaz M,
García-Armengol R, Prica CM, Andereggen E, Rinaldi L, et al:
Combining H-FABP and GFAP increases the capacity to differentiate
between CT-positive and CT-negative patients with mild traumatic
brain injury. PLoS One. 13(e0200394)2018.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Posti JP, Takala RSK, Lagerstedt L,
Dickens AM, Hossain I, Mohammadian M, Ala-Seppälä H, Frantzén J,
van Gils M, Hutchinson PJ, et al: Correlation of blood biomarkers
and biomarker panels with traumatic findings on computed tomography
after traumatic brain injury. J Neurotrauma. 36:2178–2189.
2019.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Koivikko P, Posti JP, Mohammadian M,
Lagerstedt L, Azurmendi L, Hossain I, Katila AJ, Menon D, Newcombe
VFJ, Hutchinson PJ, et al: Potential of heart fatty-acid binding
protein, neurofilament light, interleukin-10 and S100
calcium-binding protein B in the acute diagnostics and severity
assessment of traumatic brain injury. Emerg Med J EMJ. 39:206–212.
2022.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Posti JP, Takala RSK, Raj R, Luoto TM,
Azurmendi L, Lagerstedt L, Mohammadian M, Hossain I, Gill J,
Frantzén J, et al: Admission levels of interleukin 10 and amyloid β
1-40 improve the outcome prediction performance of the Helsinki
computed tomography score in traumatic brain injury. Front Neurol.
11(549527)2020.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Vedantam A, Brennan J, Levin HS, McCarthy
JJ, Dash PK, Redell JB, Yamal JM and Robertson CS: Early versus
late profiles of inflammatory cytokines after mild traumatic brain
injury and their association with neuropsychological outcomes. J
Neurotrauma. 38:53–62. 2021.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Schneider Soares FM, Menezes de Souza N,
Libório Schwarzbold M, Paim Diaz A, Costa Nunes J, Hohl A, Nunes
Abreu da Silva P, Vieira J, Lisboa de Souza R, Moré Bertotti M, et
al: Interleukin-10 is an independent biomarker of severe traumatic
brain injury prognosis. Neuroimmunomodulation. 19:377–385.
2012.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Kirchhoff C, Buhmann S, Bogner V,
Stegmaier J, Leidel BA, Braunstein V, Mutschler W and Biberthaler
P: Cerebrospinal IL-10 concentration is elevated in non-survivors
as compared to survivors after severe traumatic brain injury. Eur J
Med Res. 13:464–468. 2008.PubMed/NCBI
|
|
102
|
Matsushima K, Yang D and Oppenheim JJ:
Interleukin-8: An evolving chemokine. Cytokine.
153(155828)2022.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Whalen MJ, Carlos TM, Kochanek PM,
Wisniewski SR, Bell MJ, Clark RS, DeKosky ST, Marion DW and Adelson
PD: Interleukin-8 is increased in cerebrospinal fluid of children
with severe head injury. Crit Care Med. 28:929–934. 2000.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Hesse R, Wahler A, Gummert P, Kirschmer S,
Otto M, Tumani H, Lewerenz J, Schnack C and von Arnim CA: Decreased
IL-8 levels in CSF and serum of AD patients and negative
correlation of MMSE and IL-1β. BMC Neurol. 16(185)2016.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Rowland B, Savarraj JPJ, Karri J, Zhang X,
Cardenas J, Choi HA, Holcomb JB and Wade CE: Acute inflammation in
traumatic brain injury and polytrauma patients using network
analysis. Shock. 53:24–34. 2020.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Polat Ö, Uçkun ÖM, Tuncer C and Belen AD:
Is IL-8 level an indicator of clinical and radiological status of
traumatic brain injury? Ulus Travma Acil Cerrahi Derg. 25:193–197.
2019.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Chaban V, Clarke GJB, Skandsen T, Islam R,
Einarsen CE, Vik A, Damås JK, Mollnes TE, Håberg AK and Pischke SE:
Systemic inflammation persists the first year after mild traumatic
brain injury: Results from the prospective Trondheim mild traumatic
brain injury study. J Neurotrauma. 37:2120–2130. 2020.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Rhodes J, Sharkey J and Andrews P: Serum
IL-8 and MCP-1 concentration do not identify patients with
enlarging contusions after traumatic brain injury. J Trauma.
66:1591–1598. 2009.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Mussack T, Biberthaler P, Kanz KG,
Wiedemann E, Gippner-Steppert C, Mutschler W and Jochum M: Serum
S-100B and interleukin-8 as predictive markers for comparative
neurologic outcome analysis of patients after cardiac arrest and
severe traumatic brain injury. Crit Care Med. 30:2669–2674.
2002.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Gopcevic A, Mazul-Sunko B, Marout J,
Sekulic A, Antoljak N, Siranovic M, Ivanec Z, Margaritoni M,
Bekavac-Beslin M and Zarkovic N: Plasma interleukin-8 as a
potential predictor of mortality in adult patients with severe
traumatic brain injury. Tohoku J Exp Med. 211:387–393.
2007.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Yang B, Sun X, Shi Q, Dan W, Zhan Y, Zheng
D, Xia Y, Xie Y and Jiang L: Prediction of early prognosis after
traumatic brain injury by multifactor model. CNS Neurosci Ther.
28:2044–2052. 2022.PubMed/NCBI View Article : Google Scholar
|
